Company Monitoring Page for MannKind

latest headlines for company on cafepharma

3 Oversold Biotech Stocks Being Snapped up By Insiders
Seeking Alpha
Fri, 03/11/11 - 01:29 pm
Tags:
MannKind, Seattle Genetics, Theravance
Pomerantz Law Firm Reminds Shareholders of MannKind Corp of Upcoming Deadline
Yahoo/GlobeNewsWire
Sat, 03/5/11 - 12:22 pm
Tags:
MannKind, lawsuits
Pending FDA Approval Means Mannkind Is Down, But It's Not Out
Seeking Alpha
Thu, 03/3/11 - 08:49 am
Tags:
FDA, inhaled insulin, MannKind, Afrezza
Biotech Mailbag: BIO CEO Wrap
TheStreet.com
Fri, 02/18/11 - 09:36 am
Tags:
BIO CEO Conference, Rexahn, Nymox, MannKind, Teva Pharmaceuticals, Somaxon, Medivation, Cell Therapeutics, YM BioSciences
Earnings Setback for MannKind: Frozen in Tracks Over Afrezza?
Seeking Alpha
Tue, 02/15/11 - 09:24 am
Tags:
earnings, MannKind, Afrezza, inhaled insulin
Mannkind Slashes Staff: Biotech's Latest Tribulations
Seeking Alpha
Mon, 02/14/11 - 11:23 am
Tags:
MannKind, layoffs, AP Pharma, GSK, Pfizer, Orexigen
Is It Worth Buying the MannKind Dip?
Seeking Alpha
Sun, 02/13/11 - 10:57 am
Tags:
MannKind, Afrezza, inhaled insulin
49 Days Left - Kahn Swick & Foti, LLC and Former Louisiana Attorney General Remind Investors With Large Financial Interests (Over $100,000) of Lead Plaintiff Deadline in Lawsuit Against MannKind Corp. - MNKD
Yahoo/BusinessWire
Sat, 02/12/11 - 12:57 pm
Tags:
MannKind, lawsuits
Biotech Optimists Throw In the Towel
Motley Fool
Sat, 02/12/11 - 12:55 pm
Tags:
biotech, MannKind, Orexigen, Arena Pharmaceuticals, XenoPort, A.P. Pharma
MannKind Shares Plunged: What You Need to Know
Motley Fool
Sat, 02/12/11 - 12:18 pm
Tags:
MannKind, Afrezza, inhaled insulin, diabetes
Earnings Preview: MannKind
Yahoo/Zacks.com
Mon, 02/7/11 - 11:19 am
Tags:
earnings, MannKind
Mannkind Shares Popped: What You Need to Know
Motley Fool
Wed, 02/2/11 - 05:22 pm
Tags:
Afrezza, inhaled insulin, MannKind
5 Drugmakers Headed Back to the Drawing Board
Motley Fool
Mon, 01/31/11 - 06:54 pm
Tags:
Bydureon, Eli Lilly, Amylin, diabetes, MannKind, Afrezza, InterMune, Esbriet, IPF, Lorqess, Arena Pharmaceuticals, Vivus, Qnexa
A Foursome Of Pharma Earnings Suggests Business Is Still Tough
Investopedia
Mon, 01/31/11 - 05:07 pm
Tags:
earnings, Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, MannKind, Novartis, Vivus
Inhaled Insulin Maker Still Breathing - MannKind’s future may hinge on deep pockets of owner
LA Business Journal, CA
Tue, 01/25/11 - 12:03 pm
Tags:
MannKind, inhaled insulin, diabetes, Afrezza
FDA's Second Rejection of Mannkind's Inhaled Insulin Has Investors Worried
Seeking Alpha
Thu, 01/20/11 - 10:11 am
Tags:
FDA, inhaled insulin, MannKind, diabetes
MannKind’s Inhaled Insulin Fails to Win U.S. Approval
Bloomberg
Thu, 01/20/11 - 09:47 am
Tags:
inhaled insulin, MannKind, Afrezza, diabetes
2-Star Stocks Poised to Plunge: MannKind?
Motley Fool
Wed, 01/19/11 - 11:10 am
Tags:
MannKind
Mann doubles down on biotech as Afrezza decision looms
Fierce Biotech
Wed, 01/5/11 - 11:49 am
Tags:
diabetes, MannKind, inhaled insulin, Afrezza
Biotech 2011 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/5/11 - 11:09 am
Tags:
biotech, Celgene, Dendreon, MannKind, Vertex Pharmaceuticals, Genzyme, Ariad Pharmaceuticals, Keryx

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.